Kisqali Tablets 200mg

Product Description

Kisqali Tablets 200mg contain ribociclib, a targeted therapy used to treat certain types of hormone-dependent breast cancer. It works by inhibiting CDK4/6 proteins, helping to slow or stop the growth of cancer cells.

Product Overview

Product Name: Kisqali Tablets 200mg
Product Form: Tablets
Pack Size: 63's
Manufactured By: Novartis
Used For: Hormone receptor-positive, HER2-negative breast cancer
Prescription Required: Yes

How It Works

Ribociclib blocks CDK4 and CDK6 enzymes, which are involved in cell division. By inhibiting these proteins, it helps prevent cancer cells from multiplying. Kisqali is generally used with an aromatase inhibitor or fulvestrant as part of combination therapy for advanced or early-stage breast cancer.

Key Benefits

Used for metastatic breast cancer that has spread beyond the breast.
Helpful in early breast cancer to reduce the risk of recurrence when used with hormone therapy.
Slows cancer cell growth and enhances treatment effectiveness when combined with other medications.
Provides a targeted approach with fewer systemic effects than traditional chemotherapy.

How to Use

Use Kisqali exactly as prescribed by your oncologist.
Typically taken once daily for 21 days followed by 7 days off (28-day cycle), but the dose and schedule may vary.
Swallow the tablets whole with water and do not crush or chew them.

Side Effects and Precautions

Common Side Effects

Neutropenia (low white blood cell count)
Diarrhea
Nausea and vomiting
Fatigue
Liver enzyme elevations
Hair thinning or loss
QT prolongation, which may affect heart rhythm

Precautions

Regular blood tests are required to monitor white blood cell levels.
Frequent liver function tests are essential during treatment.
ECG monitoring may be recommended to watch for QT prolongation.
Inform your doctor about all medications and supplements to avoid interactions.
Not recommended during pregnancy or breastfeeding due to possible harm to the fetus or infant.

Who Should Use

Patients with hormone receptor-positive, HER2-negative breast cancer, either metastatic or early-stage, as part of combination therapy under the supervision of an oncologist.

Storage Instructions

Store in a cool, dry place away from light and moisture.
Keep out of reach of children and use before the expiry date.

Disclaimer

This medication must be used under medical supervision. The information provided does not replace professional medical advice. Always consult your oncologist for diagnosis, treatment decisions, and correct dosing instructions.